Rapport Therapeutics, Inc. Common StockRAPPNASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-88.09M
↓ 88% vs avg
Percentile
P0
Near historical low
Streak
3 yr
Consecutive declineContracting
Average
$-46.92M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $-88.09M | -31.0% |
| 2024 | $-67.23M | -133.3% |
| 2023 | $-28.82M | -717.3% |
| 2022 | $-3.53M | - |